bioSyntagma careers

bioSyntagma has developed a “Google Maps” for tissue that can physically map cells,gene mutations, proteins, and more from cancer patient biopsies (spatial, multi-omic) This enables the generation of a ‘Molecular Fingerprint’ that quantifies features that cause drug resistance to predict patient responses to targeted drugs and identify suggested combinations of drugs that would overcome resistance and prevent relapse. A bioSyntagma diagnostic test saves payers billions from trial-and-error treatments, helps
Pharma companies enroll the right patients into clinical trials, and truly enable personalized medicine.